For this purpose, two different T-ALL cell lines were used, the MOLT4-GPF cells as a model of CCR9+ T-ALL and the Jurkat-GFP cells as a model of CCR9- T-ALL. This evidence concerns the gene CCR9 and acute lymphoblastic leukemia.